Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Analgesic activity demonstrated for Abbott's novel nAChR ligands

Sep. 14, 2000

St. John's wort extract and imipramine equally efficacious in treating depression

Sep. 14, 2000

Researchers uncover protein key to the development of Alzheimer's

Sep. 13, 2000

Canadian lab designs 5-ht6 receptor antagonists for schizophrenia

Sep. 13, 2000

Full, selective 5-HT1A antagonist characterized as having potential in depression, smoking cessation

Sep. 13, 2000

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Sep. 13, 2000

Anticonvulsant glutamate receptor blockers in the Pfizer pipeline

Sep. 12, 2000

CGRP antagonists as a novel approach to the treatment of migraine

Sep. 12, 2000

Novel mechanism of SB-220453, a new antimigraine agent, studied in cats

Sep. 12, 2000

Studies reveal association between hypocretin deficiency and narcolepsy

Sep. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...